Return-Path: <nifl-health@literacy.nifl.gov> Received: from literacy (localhost [127.0.0.1]) by literacy.nifl.gov (8.10.2/8.10.2) with SMTP id g98FuTX29104; Tue, 8 Oct 2002 11:56:29 -0400 (EDT) Date: Tue, 8 Oct 2002 11:56:29 -0400 (EDT) Message-Id: <001001c26ee2$bcc422b0$d8f06083@ED856ALCDGG1> Errors-To: listowner@literacy.nifl.gov Reply-To: nifl-health@literacy.nifl.gov Originator: nifl-health@literacy.nifl.gov Sender: nifl-health@literacy.nifl.gov Precedence: bulk From: "Daphen Greenberg" <epedgg@panther.Gsu.EDU> To: Multiple recipients of list <nifl-health@literacy.nifl.gov> Subject: [NIFL-HEALTH:3790] primary peritoneal cancer and the tumor marker CA-125 blood test X-Listprocessor-Version: 6.0c -- ListProcessor by Anastasios Kotsikonas X-Mailer: Microsoft Outlook Express 6.00.2600.0000 Content-Transfer-Encoding: 7bit Content-Type: text/plain; Status: O Content-Length: 714 Lines: 21 There has been an email floating around about primary peritoneal cancer and the tumor marker CA-125 blood test. I am hoping that the medical professionals on this listserv can shed some insight into this, so that we can know how to direct our learners. According to the email, one out of every 55 women will get ovarian or primary peritoneal cancer and it is urged that women ask their doctors to run the CA-125 blood test as part of an annual physical exam. Apparently, this blood test is inexpensive and simple. Is there anyone on this listserv who can shed light on this and do you know of easy to read websites or printed materials that discuss this? Thanks! Daphne Greenberg Georiga State University
This archive was generated by hypermail 2b30 : Fri Jan 17 2003 - 14:41:35 EST